Back to Newsroom

United Neuroscience and University of Texas Southwestern Medical Center Announce Collaboration to Evaluate Endobody Vaccine Candidates Directed at Tau Protein for the Treatment and Prevention of Alzheimer’s Disease

DUBLINApril 11, 2018 /PRNewswire/ — United Neuroscience, Ltd., (UNS), today announced that it has signed a collaboration agreement with the Center for Alzheimer’s and Neurodegenerative Diseases at the University of Texas Southwestern Medical Center to identify distinct pathogenic species of tau protein and evaluate promising therapeutic vaccine candidates to contribute to therapies for Alzheimer’s and other neurodegenerative diseases. As part of the collaboration, the Center for Alzheimer’s and Neurodegenerative Diseases will test United Neuroscience Endobody vaccine candidates using human postmortem tissue samples and preclinical models of neurodegenerative disease.